St. Jude Children's Research Hospital, Inc.

St. Jude Children's Research Hospital is a pediatric treatment and research institution headquartered in Memphis, Tennessee. Its core mission is to advance cures and means of prevention for pediatric catastrophic diseases through research and treatment, ensuring that no child is denied care based on race, religion, or a family's ability to pay.

The hospital specializes in treating children with cancer, blood disorders, neurological disorders, infectious diseases, and other life-threatening conditions. It holds the distinction of being the first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated solely to children. St. Jude also provides comprehensive support to patient families, covering costs for treatment, travel, housing, and food. The institution extends its reach globally through programs like the International Outreach Program and St. Jude Global, aiming to improve survival rates for children worldwide.

James R. Downing serves as the CEO and President, with plans to step down in late 2026. St. Jude consistently ranks among the top children's cancer hospitals in the U.S. by U.S. News & World Report. The hospital is currently undertaking a significant $12.9 billion strategic investment to expand research areas, programs, and facilities, reflecting its ongoing commitment to pioneering advancements in pediatric medicine.